Figure 2
Figure 2. TF isoforms exert cellular effects via PAR2 and integrin ligation. The membrane-bound flTF/FVIIa complex signals via the G-coupled PAR24,24,25,30,31,43 when coupled to α6β1 or α3β1 integrins.28–30 The phosphorylation status of the flTF cytoplasmic domain balances protease activated receptor (PAR2) signaling.27,29,31 asTF ligates α6β1 and αVβ3 integrins, leading to signaling via focal adhesion kinases (FAK), independent of FVIIa and PAR2.5 The resulting signaling pathways regulate cell survival and motility and induce release of angiogenic factors.4,5,23,24,25,30 PI3 indicates phosphatidylinositol-3′; MAP, mitogen-activated protein; CXCL-1, chemokine ligand-1; and VEGF, vascular endothelial growth factor.

TF isoforms exert cellular effects via PAR2 and integrin ligation. The membrane-bound flTF/FVIIa complex signals via the G-coupled PAR24,24,25,30,31,43  when coupled to α6β1 or α3β1 integrins.28-30  The phosphorylation status of the flTF cytoplasmic domain balances protease activated receptor (PAR2) signaling.27,29,31  asTF ligates α6β1 and αVβ3 integrins, leading to signaling via focal adhesion kinases (FAK), independent of FVIIa and PAR2. The resulting signaling pathways regulate cell survival and motility and induce release of angiogenic factors.4,5,23-25,30  PI3 indicates phosphatidylinositol-3′; MAP, mitogen-activated protein; CXCL-1, chemokine ligand-1; and VEGF, vascular endothelial growth factor.

Close Modal

or Create an Account

Close Modal
Close Modal